Cobamamide
CAS 13870-90-1
Cobamamide (CAS 13870-90-1) is a pharmaceutical compound with 0 bioactivity targets and 1,639 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Ultrasound antenatal screen | 20 | 118.846 | 10045399 |
| Trisomy 18 | 20 | 113.354 | 10053884 |
| Hydrops foetalis | 21 | 109.255 | 10020529 |
| Cleft lip and palate | 20 | 96.62 | 10009260 |
| Ejection fraction abnormal | 14 | 62.855 | 10014331 |
| Sensitisation | 14 | 59.797 | 10070834 |
| Polycystic ovaries | 14 | 56.819 | 10036049 |
| Needle fatigue | 10 | 50.738 | 10077304 |
| Gait spastic | 10 | 47.628 | 10017585 |
| Carpal tunnel syndrome | 18 | 46.403 | 10007697 |
| Relapsing-remitting multiple sclerosis | 10 | 45.98 | 10063399 |
| Drug-induced liver injury | 23 | 41.189 | 10072268 |
| Hepatic cytolysis | 17 | 40.568 | 10049199 |
| Rhinitis allergic | 14 | 40.185 | 10039085 |
| Intentional product use issue | 34 | 38.249 | 10076308 |
| Blood test abnormal | 15 | 37.724 | 10061016 |
| Monoparesis | 10 | 37.563 | 10027925 |
| Sleep disorder due to a general medical condition | 14 | 36.071 | 10063910 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| cobamamide | 21373 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Cobamamide used for in pharmaceutical contexts?
Cobamamide (CAS 13870-90-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Cobamamide?
Cobamamide has 1,639 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Ultrasound antenatal screen, Trisomy 18, Hydrops foetalis, Cleft lip and palate, Ejection fraction abnormal. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Cobamamide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Cobamamide with EU status "permitted".
What clinical phase is Cobamamide in?
No phase 1-4 clinical development badge is rendered for Cobamamide because the matched compound identifier rows do not contain a max-phase value.